Jochen Kinter

1.2k total citations
21 papers, 895 citations indexed

About

Jochen Kinter is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Jochen Kinter has authored 21 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Jochen Kinter's work include Genetic Neurodegenerative Diseases (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Muscle Physiology and Disorders (3 papers). Jochen Kinter is often cited by papers focused on Genetic Neurodegenerative Diseases (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Muscle Physiology and Disorders (3 papers). Jochen Kinter collaborates with scholars based in Switzerland, United States and Germany. Jochen Kinter's co-authors include P. Sonderegger, Renato Frischknecht, Virginia Meskenaïte, Paolo Cinelli, Luigi Tornillo, Alexander Akhmedov, David P Wolfer, Hans‐Peter Lipp, Rime Madani and Markus H. Heim and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Hepatology.

In The Last Decade

Jochen Kinter

20 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jochen Kinter Switzerland 12 454 271 177 171 146 21 895
Myrna A.R. Dent Mexico 15 500 1.1× 115 0.4× 138 0.8× 314 1.8× 79 0.5× 29 858
Konstantin Adamsky Israel 17 681 1.5× 116 0.4× 166 0.9× 171 1.0× 101 0.7× 25 1.3k
Zofia M. Lasiecka United States 11 564 1.2× 367 1.4× 148 0.8× 287 1.7× 206 1.4× 14 968
Jonathan D. Leslie United Kingdom 12 1.0k 2.3× 571 2.1× 134 0.8× 301 1.8× 92 0.6× 13 1.5k
Marie Wattenhofer‐Donzé France 16 779 1.7× 158 0.6× 50 0.3× 305 1.8× 126 0.9× 19 1.1k
Sachiko Kamakura Japan 16 1.2k 2.7× 338 1.2× 164 0.9× 173 1.0× 122 0.8× 33 1.7k
Shalom Guy Slutsky Israel 7 663 1.5× 160 0.6× 105 0.6× 147 0.9× 335 2.3× 8 1.1k
Anastasia P. Grigorenko Russia 18 664 1.5× 124 0.5× 222 1.3× 120 0.7× 172 1.2× 34 1.1k
Filip A. Konopacki United Kingdom 15 681 1.5× 173 0.6× 293 1.7× 430 2.5× 96 0.7× 17 1.1k
T. Norene O’Sullivan United States 9 1.1k 2.4× 544 2.0× 84 0.5× 484 2.8× 129 0.9× 15 1.6k

Countries citing papers authored by Jochen Kinter

Since Specialization
Citations

This map shows the geographic impact of Jochen Kinter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Kinter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Kinter more than expected).

Fields of papers citing papers by Jochen Kinter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jochen Kinter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Kinter. The network helps show where Jochen Kinter may publish in the future.

Co-authorship network of co-authors of Jochen Kinter

This figure shows the co-authorship network connecting the top 25 collaborators of Jochen Kinter. A scholar is included among the top collaborators of Jochen Kinter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jochen Kinter. Jochen Kinter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Shuo, Lionel Tintignac, Robert Ivánek, et al.. (2024). CaMKIIβ deregulation contributes to neuromuscular junction destabilization in Myotonic Dystrophy type I. Skeletal Muscle. 14(1). 11–11. 5 indexed citations
2.
Ashley, Jon, Ke Shi, Michael Kyba, et al.. (2020). DNA aptamers against the DUX4 protein reveal novel therapeutic implications for FSHD. The FASEB Journal. 34(3). 4573–4590. 24 indexed citations
3.
Erne, Beat, Frances Kern, Matthias Hamburger, et al.. (2016). Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I. Journal of Biological Chemistry. 291(33). 17165–17177. 15 indexed citations
4.
Kinter, Jochen, et al.. (2015). Genetic characterization and improved genotyping of the dysferlin-deficient mouse strain Dysf tm1Kcam. Skeletal Muscle. 5(1). 32–32. 4 indexed citations
5.
Kinter, Jochen & Michael Sinnreich. (2014). Molecular targets to treat muscular dystrophies. Swiss Medical Weekly. 144(708). w13916–w13916. 7 indexed citations
6.
Kinter, Jochen, Jürgen Hench, Stephan Frank, et al.. (2012). Novel valosin containing protein mutation in a Swiss family with hereditary inclusion body myopathy and dementia. Neuromuscular Disorders. 23(2). 149–154. 10 indexed citations
7.
Kinter, Jochen, Thomas Zeis, Beat Erne, et al.. (2012). An essential role of MAG in mediating axon–myelin attachment in Charcot–Marie–Tooth 1A disease. Neurobiology of Disease. 49. 221–231. 30 indexed citations
8.
Steck, Andreas, Jochen Kinter, & Susanne Renaud. (2011). Neuropathies des vascularites : l’apport des techniques à puces d’ADN dans les biopsies de nerf. Revue Neurologique. 167(12). 927–929.
9.
Steck, Andreas, Jochen Kinter, & Susanne Renaud. (2011). Differential gene expression in nerve biopsies of inflammatory neuropathies. Journal of the Peripheral Nervous System. 16(s1). 30–33. 12 indexed citations
10.
Kinter, Jochen, Laura Broglio, Andreas Steck, et al.. (2010). Gene expression profiling in nerve biopsy of vasculitic neuropathy. Journal of Neuroimmunology. 225(1-2). 184–189. 9 indexed citations
11.
Kinter, Jochen, Igor Allaman, Kate Schroder, et al.. (2009). Cellular Immunity And Pathological Alterations In Ms Grey Matter. Glia. 57. 1 indexed citations
12.
Tchorz, Jan S., Jochen Kinter, Mathias Müller, et al.. (2009). Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice #. Hepatology. 50(3). 871–879. 90 indexed citations
14.
Kinter, Jochen, Thomas Zeis, & Nicole Schaeren‐Wiemers. (2008). RNA profiling of MS brain tissues.. PubMed. 15(2). 51–8. 18 indexed citations
15.
Galliciotti, Giovanna, Markus Glatzel, Jochen Kinter, et al.. (2007). Accumulation of Mutant Neuroserpin Precedes Development of Clinical Symptoms in Familial Encephalopathy with Neuroserpin Inclusion Bodies. American Journal Of Pathology. 170(4). 1305–1313. 31 indexed citations
16.
Madani, Rime, Serguei Kozlov, Alexander Akhmedov, et al.. (2003). Impaired explorative behavior and neophobia in genetically modified mice lacking or overexpressing the extracellular serine protease inhibitor neuroserpin. Molecular and Cellular Neuroscience. 23(3). 473–494. 120 indexed citations
17.
Vogt, Lorenz, Sabine Schrimpf, Virginia Meskenaïte, et al.. (2001). Calsyntenin-1, a Proteolytically Processed Postsynaptic Membrane Protein with a Cytoplasmic Calcium-Binding Domain. Molecular and Cellular Neuroscience. 17(1). 151–166. 90 indexed citations
18.
Kozlov, Serguei, Mariluce Riegel, Jochen Kinter, et al.. (1999). Assignment<footref rid="foot01"><sup>1</sup></footref> of the gene encoding the neuronal multidomain serine protease neurotrypsin (PRSS12) to human chromosome band 4q25→q26 by in situ hybridization. Cytogenetic and Genome Research. 84(1-2). 107–108. 3 indexed citations
19.
Davis, Richard L., Antony E. Shrimpton, P D Holohan, et al.. (1999). Familial dementia caused by polymerization of mutant neuroserpin. Nature. 401(6751). 376–379. 283 indexed citations
20.
Davis, Richard L., P D Holohan, Charles R. Bradshaw, et al.. (1999). Familial dementia caused by polymerization of mutant neuroserpin. Nature. 401(6751). 376–379. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026